The global blood group typing market is highly competitive, with several players operating in the market. The major players in the market include Grifols, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Immucor, Inc., Quotient Limited, BAG Health Care GmbH, and BioMérieux SA, among others. These players are focusing on developing innovative products and expanding their market presence through mergers, acquisitions, and partnerships.

The market can be segmented based on product type, test type, technique, end-user, and geography. Based on product type, the market can be segmented into reagents and consumables, instruments, and services. The reagents and consumables segment accounted for the largest share of the market in 2020, owing to the high demand for these products in blood typing procedures.

Based on test type, the market can be segmented into antibody screening, HLA typing, ABO blood tests, and cross-matching. The ABO blood tests segment accounted for the largest share of the market in 2020, owing to the high demand for ABO blood grouping in blood transfusion procedures.

Based on technique, the market can be segmented into PCR-based and microarray techniques, mass spectrometry, and serological techniques. The PCR-based and microarray techniques segment accounted for the largest share of the market in 2020, owing to the high accuracy and efficiency of these techniques in blood typing procedures.

Based on end-user, the market can be segmented into hospitals and diagnostic laboratories, blood banks, and other end-users. The hospitals and diagnostic laboratories segment accounted for the largest share of the market in 2020, owing to the high demand for blood typing procedures in these facilities.

Geographically, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America accounted for the largest share of the market in 2020, owing to the high prevalence of blood disorders, rising demand for blood transfusions and organ transplantation, and the presence of major players in the region.

The Asia Pacific region is expected to witness significant growth in the coming years, owing to the increasing incidence of blood disorders, rising demand for blood transfusions and organ transplantation, and the improving healthcare infrastructure in the region. Moreover, the increasing focus of major players on expanding their market presence in the region is expected to further drive the growth of the market.

The market is witnessing several growth opportunities, such as the increasing demand for personalized medicine and the rising adoption of point-of-care testing. The increasing demand for personalized medicine is driving the development of targeted therapies that require precise blood group typing procedures. For instance, in July 2020, Immucor, Inc. announced the launch of its MIA FORA NGS Flex HLA Typing Assay, a high-resolution sequencing assay that provides precise and reliable results for HLA typing.

The rising adoption of point-of-care testing is enabling healthcare professionals to perform blood group typing procedures at the patient's bedside, which is improving the efficiency and speed of the procedure. For instance, in May 2021, Grifols announced the launch of its Erytra Eflexis, a fully automated blood typing system that provides accurate and reliable results in just a few minutes.